CN109602696A - A kind of chlorhexidine acetate bacteriostatic gel and preparation method thereof - Google Patents

A kind of chlorhexidine acetate bacteriostatic gel and preparation method thereof Download PDF

Info

Publication number
CN109602696A
CN109602696A CN201910097605.XA CN201910097605A CN109602696A CN 109602696 A CN109602696 A CN 109602696A CN 201910097605 A CN201910097605 A CN 201910097605A CN 109602696 A CN109602696 A CN 109602696A
Authority
CN
China
Prior art keywords
parts
extract
chlorhexidine acetate
composition
kuh
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
CN201910097605.XA
Other languages
Chinese (zh)
Inventor
林敏�
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Jiangxi Dengyun Health Beauty Industry Internet Ltd
Original Assignee
Jiangxi Dengyun Health Beauty Industry Internet Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jiangxi Dengyun Health Beauty Industry Internet Ltd filed Critical Jiangxi Dengyun Health Beauty Industry Internet Ltd
Priority to CN201910097605.XA priority Critical patent/CN109602696A/en
Publication of CN109602696A publication Critical patent/CN109602696A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
    • A61K36/234—Cnidium (snowparsley)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/484—Glycyrrhiza (licorice)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/489—Sophora, e.g. necklacepod or mamani
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A61K36/533—Leonurus (motherwort)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Mycology (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gynecology & Obstetrics (AREA)
  • Reproductive Health (AREA)
  • Organic Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Endocrinology (AREA)
  • Oncology (AREA)
  • Urology & Nephrology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)

Abstract

The invention discloses a kind of chlorhexidine acetate bacteriostatic gels, it include: 0.05-0.3 parts of kuh-seng root extract, 0.05-0.3 parts of cnidium monnieri berry extract, 0.1-0.5 parts of Leonurus extract, 0.05-0.3 parts of Gotu Kola P.E, 0.1-0.5 parts of purslane extract, 0.05-0.3 parts of glycyrrhiza glabra extract, 0.3-0.8 parts of Fructus Kochiae extract；0.4-0.6 parts of ethyl alcohol, 0.1-0.2 parts of chlorhexidine acetate；1-3 parts of hydroxyethyl cellulose, 4-6 parts of glycerol, 1-3 parts of propylene glycol, 88-90 parts of water.The present invention is by the way that by the kuh-seng root extract of certain content, cnidium monnieri berry extract, Leonurus extract, Gotu Kola P.E, purslane extract, glycyrrhiza glabra extract, Fructus Kochiae extract, totally seven kinds of Chinese medical extracts carry out each components 5 and match and the synergistic function of drug effect, it is aided with the components such as the chlorhexidine acetate of certain content, the chlorhexidine acetate bacteriostatic gel being prepared to Escherichia coli, staphylococcus aureus, Candida albicans bacteriostasis rate have 90% or more fungistatic effect, female vulva itch, peculiar smell, the symptom of vaginitis can significantly be mitigated.

Description

A kind of chlorhexidine acetate bacteriostatic gel and preparation method thereof
Technical field
The present invention relates to pharmaceutical technology fields, and in particular to a kind of chlorhexidine acetate bacteriostatic gel and preparation method thereof.
Background technique
Women's health is more and more paid close attention to, and various Gynecological health articles occurs.General health treatment is more For oral preparation, its health effect is very unobvious, has larger side effect, and hormone-content is high, easily leads to human body interior point Secrete imbalance.External drug is big to skin irritation, allergic symptom easily occurs and the problem of without bactericidal effect, and in the market mostly For number product based on Chinese materia medica preparation, general fungistatic effect is bad.Furthermore there are also suppository classes, lotion for the antimicrobial for the treatment of gynaecological imflammation Class, spray class etc., but most drugs can generate destruction to genital tract environment, mucous membrane itself secreting function, so as to cause reproduction The decline of local immunity, and pathogenic bacteria is caused to develop drug resistance and drug resistance, final inflammation recurrent exerbation.
It, should if Chinese invention patent application CN201210039685.1 describes a kind of germicide for skin and preparation method thereof Germicide for skin includes ginkgo leaf juice, feverfew juice, RADIX SOLANI juice, kudzuvine root juice, argy wormwood leaf juice, purslane extract, Bulbus Allii Fistulosi juice, distillation The components such as water.But the antibacterial agent fungistatic effect is poor, and cannot effectively treat gynecological disease and cleaning skin, Chinese materia medica preparation conduct Bacteriostatic agent, fungistatic effect are poor.
Summary of the invention
It is in view of the above-mentioned drawbacks of the prior art or insufficient, the primary purpose of the present invention is that providing a kind of fungistatic effect Good, curative effect is stablized, and is able to maintain the clean chlorhexidine acetate bacteriostatic gel of women privates.The gelling agent is to Escherichia coli, gold Staphylococcus aureus, Candida albicans bacteriostasis rate have 90% or more fungistatic effect, can significantly mitigate female vulva scabies Itch, peculiar smell, the symptom of vaginitis.
Another object of the present invention is to provide the preparation method of above-mentioned chlorhexidine acetate bacteriostatic gel.
Chlorhexidine acetate bacteriostatic gel of the present invention, by weight, including following component:
0.05-0.3 parts of kuh-seng root extract, 0.05-0.3 parts of cnidium monnieri berry extract, 0.1-0.5 parts of Leonurus extract, accumulated snow Careless extract 0.05-0.3 parts, 0.1-0.5 parts of purslane extract, 0.05-0.3 parts of glycyrrhiza glabra extract, the fruit of summer cypress extracts 0.3-0.8 parts of object；
0.4-0.6 parts of ethyl alcohol, 0.1-0.2 parts of chlorhexidine acetate；
1-3 parts of hydroxyethyl cellulose, 4-6 parts of glycerol, 1-3 parts of propylene glycol, 88-90 parts of water.
Preferably, chlorhexidine acetate bacteriostatic gel of the present invention, by weight, including following component:
0.1 part of kuh-seng root extract, 0.1 part of cnidium monnieri berry extract, 0.2 part of Leonurus extract, 0.1 part of Gotu Kola P.E, 0.2 part of purslane extract, 0.1 part of glycyrrhiza glabra extract, 0.5 part of Fructus Kochiae extract；
0.5 part of ethyl alcohol, 0.12 part of chlorhexidine acetate；
2 parts of hydroxyethyl cellulose, 5 parts of glycerol, 2 parts of propylene glycol, 89.08 parts of water.
Radix sophorae is the root of kuh-seng Sophora flavescens Ait., and bitter is cold in nature, has heat-clearing and damp-drying drug, diuresis Antipyretic, wind-dispelling stops skin and itches, bitter taste stomach invigorating, and the function of expelling parasite sterilization cures mainly enteritis and dysentery, enterorrhagia, hemorrhoid hemorrhage, hepatitis jaundice, Eczema, pudendal pruritus, psoriasis, boil, lambliasis.
Cnidium monnieri fruit is the dry mature fruit of umbelliferae cnidium monnieri Cnidium monnieri (L.) Cuss..It is distributed in The ground such as East China, Central-South, southwestern, northwest, North China, northeast.With the effect of eliminating dampness wind-dispelling, desinsection is antipruritic, warming kidney and enhancing body.It is usually used in Pruritus vulvae leukorrhagia, eczema itch, arthritis with fixed pain caused by dampness pain in the loins, impotence due to deficiency of the kidney, uterus cold infertile.
Motherwort is Labiatae, mother wort plant, summer-flowering.Its dry aerial parts is conventional Chinese medicine, and China is big Some areas produce, and raw use or cook paste are used.1 year or biennial herb whole nation most area are distributed, and are born in hill famine Ground, ridge, meadow etc..It is picked in the summer riotous growth non-standard-sized sheet of flower, acrid flavour is bitter, cool, invigorates blood circulation, silt of dispelling, menstruation regulating, disappear water, controls Menoxenia is treated, vaginal bleeding during pregnancy is had difficult labour, placenta retension, postpartum anemic fainting, abdominal pain due to blood stasis, metrorrhagia and metrostaxis, and hematuria rushes down blood, carbuncle swells sore Ulcer.
Centella is Umbelliferae perennial herb, and stem is crawled, elongated, is taken root on section.All herbal medicine, clearing heat and promoting diuresis, detumescence Removing toxic substances, controls acute diseases such as cholera and sunstroke xenon abdominal pain, heat rushes down, the leaching of dysentery, jaundice with damp-heat pathogen, sand, blood strangury, spit, blood, hemoptysis, hot eyes, larynx are swollen, rubeola, scabies, Malignant boil carbuncle swells poison, traumatic injury etc..
Purslane is Caryophyllales, Portulacaceae annual herb, and complete stool is hairless.Herb hyoscine has clearing heat and promoting diuresis, removing toxic substances Detumescence anti-inflammatory, is quenched the thirst, diuresis.
Glycyrrhiza glabra, the generally referred to as stem of glycyrrhiza glabra, main component are that glycyrrhiza glabra element and glycyrrhiza glabra are fixed, are had It antioxygenic activity very strong depigmentation of skin, the function that lightens the stain.And antibacterial anti-inflammatory, anti-oxidant, anti-aging, antiultraviolet, it is sun-proof, Whitening skin lightening, nti-freckle and other effects are obvious.
The fruit of summer cypress is the dry mature fruit of chenopod summer cypress, and China's most area is distributed, cold in nature, sweet in flavor Hardship has clearing heat and promoting diuresis, dispelling wind and arresting itching and other effects, for diseases such as difficulty and pain in micturition, pruritus vulvae leukorrhagia, rubeola, eczema, pruituses. It mainly contains the chemical components such as triterpenoid saponin, volatile oil and flavones, has resisting pathogenic microbes, anti-inflammatory, antiallergy, hypoglycemic With the pharmacological activity such as anti-mucosal lesion, modern studies have found that fruit of summer cypress water extract has centainly a variety of common pathogens of gynaecological disease Inhibiting effect, gynaecological disease control aspect have a better effect.
Chlorhexidine acetate bacteriostatic gel of the present invention is mainly by radix sophorae, cnidium monnieri fruit, motherwort, centella, purslane, light Fruit Radix Glycyrrhizae, seven kinds of the fruit of summer cypress have heat-clearing and damp-drying drug, desinsection is antipruritic, wind-dispelling removing toxic substances Chinese medical extract composition, play Chinese medicine compound prescription Integrally-regulated advantage, the growth and breeding of various bacteria can be significantly inhibited, to Escherichia coli, staphylococcus aureus, white The bacteriostasis rate of candida albicans etc. has 90% or more fungistatic effect.
In addition, the present invention also provides the preparation methods of above-mentioned chlorhexidine acetate bacteriostatic gel, comprising the following steps:
(1) by hydroxyethyl cellulose, glycerol, mixed with propylene glycol, water is added after hydroxyethyl cellulose dissolution in stirring, and stirring adds Heat keeps the temperature 20 minutes to 95 DEG C, and composition A is made；
Kuh-seng root extract, cnidium monnieri berry extract, Leonurus extract, Gotu Kola P.E, purslane extract, light fruit is sweet Careless extract, Fructus Kochiae extract mixing, are made composition B；
Chlorhexidine acetate is dissolved in ethyl alcohol, composition C is made；
(2) composition A is cooled to 45 DEG C, composition B is then added, stirs evenly；
(3) continue to be cooled to 40 DEG C or less obtained gels under stiring, composition C is added, stirs evenly, obtains chlorhexidine acetate Bacteriostatic gel.
The chlorhexidine acetate bacteriostatic gel that the present invention is prepared, when use can it is filling in disposable vaginal to gel It is administered in device, uses 3.5g every time.
Compared with prior art, beneficial effects of the present invention are as follows:
1) present invention is by extracting the kuh-seng root extract of certain content, cnidium monnieri berry extract, Leonurus extract, centella Object, purslane extract, glycyrrhiza glabra extract, Fructus Kochiae extract totally seven kinds of Chinese medical extracts carry out each components 5 match and The synergistic function of drug effect is aided with the components such as the chlorhexidine acetate of certain content, and the chlorhexidine acetate being prepared is antibacterial solidifying Jelly to Escherichia coli, staphylococcus aureus, Candida albicans bacteriostasis rate have 90% or more fungistatic effect, Neng Gouxian It writes and mitigates female vulva itch, peculiar smell, the symptom of vaginitis, and it is uneasy to recur, so as to effectively keep women privates to clean.
2) preparation method of chlorhexidine acetate bacteriostatic gel of the present invention, it is simple to operation, it is suitable for large-scale work Industry metaplasia produces.
Specific embodiment
Further illustrate that the present invention, following embodiment are the specific embodiment party of the present invention below by specific embodiment Formula, but embodiments of the present invention are not limited by following embodiments.
Each component employed in the embodiment of the present invention is commercially available in market.
The inhibitory effect measuring method of the gelling agent, specific as follows:
(1) it is as shown in table 1 to measure strain used for strain inhibitory effect:
Table 1
Experimental strain Assay medium Cultivation temperature/DEG C Incubation time
Escherichia coli Pancreas junket soya peptone agar medium or pancreas junket soya peptone fluid nutrient medium 30-35 18-24h
Staphylococcus aureus Pancreas junket soya peptone agar medium or pancreas junket soya peptone fluid nutrient medium 30-35 18-24h
Candida albicans Pancreas junket soya peptone agar medium or pancreas junket soya peptone fluid nutrient medium 20-25 24-48h
(2) prepared by bacterium solution
If agar culture, suitable 0.9% aseptic sodium chloride solution is added and elutes the culture of agar surface, and by bacterium Suspension moves in sterile test tube, and being diluted with 0.9% aseptic sodium chloride solution and every 1ml is made containing bacterium number is about 108The bacterium of cfu is outstanding Liquid；If fluid nutrient medium, thalline were collected by centrifugation, is diluted with 0.9% aseptic sodium chloride solution and every 1ml is made containing bacterium number and be about 108The bacteria suspension of cfu.
If being placed at room temperature after bacterium solution preparation, used in Ying 2h；If being stored in 2-8 DEG C, can be used interior for 24 hours.
(3) it is inoculated with
To each strain, 3-5 parts of inventive gel are taken, is directly inoculated with；Or appropriate inventive gel is taken to be transferred to 9-15 respectively In a suitable sterile chamber (every 3-5 container is inoculated with a strain), connecing bacterium amount in 1g or 1ml gel is 105-106Cfu connects The volume of kind bacterium solution must not exceed the 1% of inoculation gel volume；It is sufficiently mixed, is uniformly distributed the strain in gel, then sets 20-25 DEG C of stored protected from light.
(4) survival Counting alive microbial
In defined interval time, 1ml(g is sampled from above-mentioned each container respectively), bacterium number contained in every part of sample is tested, To be converted into corresponding bacteriostasis rate.
Embodiment 1
A kind of chlorhexidine acetate bacteriostatic gel, by weight, including following component:
0.1 part of kuh-seng root extract, 0.1 part of cnidium monnieri berry extract, 0.2 part of Leonurus extract, 0.1 part of Gotu Kola P.E, 0.2 part of purslane extract, 0.1 part of glycyrrhiza glabra extract, 0.5 part of Fructus Kochiae extract；
0.5 part of ethyl alcohol, 0.12 part of chlorhexidine acetate；
2 parts of hydroxyethyl cellulose, 5 parts of glycerol, 2 parts of propylene glycol, 89.08 parts of water.
The preparation method of chlorhexidine acetate bacteriostatic gel of the present invention, includes the following steps:
(1) by hydroxyethyl cellulose, glycerol, mixed with propylene glycol, water is added after hydroxyethyl cellulose dissolution in stirring, and stirring adds Heat keeps the temperature 20 minutes to 95 DEG C, and composition A is made；
Kuh-seng root extract, cnidium monnieri berry extract, Leonurus extract, Gotu Kola P.E, purslane extract, light fruit is sweet Careless extract, Fructus Kochiae extract mixing, are made composition B；
Chlorhexidine acetate is dissolved in ethyl alcohol, composition C is made；
(2) composition A is cooled to 45 DEG C, composition B is then added, stirs evenly；
(3) continue to be cooled to 40 DEG C or less obtained gels under stiring, composition C is added, stirs evenly, obtains chlorhexidine acetate Bacteriostatic gel.
Embodiment 2
0.3 part of kuh-seng root extract, 0.05 part of cnidium monnieri berry extract, 0.1 part of Leonurus extract, 0.3 part of Gotu Kola P.E, 0.1 part of purslane extract, 0.05 part of glycyrrhiza glabra extract, 0.8 part of Fructus Kochiae extract；Other are the same as embodiment 1.
Embodiment 3
0.05 part of kuh-seng root extract, 0.3 part of cnidium monnieri berry extract, 0.5 part of Leonurus extract, Gotu Kola P.E 0.05 Part, 0.5 part of purslane extract, 0.3 part of glycyrrhiza glabra extract, 0.3 part of Fructus Kochiae extract；Other are the same as embodiment 1.
The test result of the fungistatic effect of chlorhexidine acetate bacteriostatic gel described in 2 embodiment 1-3 of table
Embodiment 1 Embodiment 2 Embodiment 3
The bacteriostasis rate of Escherichia coli 95% 93% 91%
The bacteriostasis rate of staphylococcus aureus 96% 92% 93%
The bacteriostasis rate of Candida albicans 95% 92% 92%
Clinical testing data:
Choose 3 patients, using embodiment 1 prepare chlorhexidine acetate bacteriostatic gel, it is filling in disposable vaginal to gel It is administered in device, continues 30 days, specific example is as follows one time a day using 3.5g every time:
Test example 1: Zhu；38 years old, has there is the vaginas aging premonitory symptom such as pruritus of vagina, lower body peculiar smell, abnormal leucorrhea in female；
The course for the treatment of: from April 17,17 days to 2018 March in 2018, adhere to being administered with chlorhexidine acetate bacteriostatic gel daily；
Curative effect: foregoing conditions all significantly mitigate.Therapeutic index is 100%.
Test example 2: what certain, female, 50 years old, bacterial infection, trichomonas, colpomycosis, vagina aging start plus Speed；
The course for the treatment of: from June 4,4 days to 2018 May in 2018, adhere to being administered with chlorhexidine acetate bacteriostatic gel daily；
Curative effect: foregoing conditions all significantly mitigate.Therapeutic index is 99%.
Test example 3: Mr. Wang, female 30 years old, cause germ often to be invaded because of vaginal relaxation, inflammation relapse indications repeatedly；
The course for the treatment of: from August on September 27th, 27,1 2018, adhere to being administered with chlorhexidine acetate bacteriostatic gel daily；
Curative effect: foregoing conditions all significantly mitigate.Therapeutic index is 100%.

Claims (3)

1. a kind of chlorhexidine acetate bacteriostatic gel, which is characterized in that by weight, including following component:
0.05-0.3 parts of kuh-seng root extract, 0.05-0.3 parts of cnidium monnieri berry extract, 0.1-0.5 parts of Leonurus extract, accumulated snow Careless extract 0.05-0.3 parts, 0.1-0.5 parts of purslane extract, 0.05-0.3 parts of glycyrrhiza glabra extract, the fruit of summer cypress extracts 0.3-0.8 parts of object；
0.4-0.6 parts of ethyl alcohol, 0.1-0.2 parts of chlorhexidine acetate；
1-3 parts of hydroxyethyl cellulose, 4-6 parts of glycerol, 1-3 parts of propylene glycol, 88-90 parts of water.
2. chlorhexidine acetate bacteriostatic gel according to claim 1, which is characterized in that by weight, including it is as follows Component:
0.1 part of kuh-seng root extract, 0.1 part of cnidium monnieri berry extract, 0.2 part of Leonurus extract, 0.1 part of Gotu Kola P.E, 0.2 part of purslane extract, 0.1 part of glycyrrhiza glabra extract, 0.5 part of Fructus Kochiae extract；
0.5 part of ethyl alcohol, 0.12 part of chlorhexidine acetate；
2 parts of hydroxyethyl cellulose, 5 parts of glycerol, 2 parts of propylene glycol, 89.08 parts of water.
3. a kind of preparation method of chlorhexidine acetate bacteriostatic gel as claimed in claim 1 or 2, which is characterized in that including with Lower step:
(1) by hydroxyethyl cellulose, glycerol, mixed with propylene glycol, water is added after hydroxyethyl cellulose dissolution in stirring, and stirring adds Heat keeps the temperature 20 minutes to 95 DEG C, and composition A is made；
Kuh-seng root extract, cnidium monnieri berry extract, Leonurus extract, Gotu Kola P.E, purslane extract, light fruit is sweet Careless extract, Fructus Kochiae extract mixing, are made composition B；
Chlorhexidine acetate is dissolved in ethyl alcohol, composition C is made；
(2) composition A is cooled to 45 DEG C, composition B is then added, stirs evenly；
(3) continue to be cooled to 40 DEG C or less obtained gels under stiring, composition C is added, stirs evenly, obtains chlorhexidine acetate Bacteriostatic gel.
CN201910097605.XA 2019-01-31 2019-01-31 A kind of chlorhexidine acetate bacteriostatic gel and preparation method thereof Withdrawn CN109602696A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201910097605.XA CN109602696A (en) 2019-01-31 2019-01-31 A kind of chlorhexidine acetate bacteriostatic gel and preparation method thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201910097605.XA CN109602696A (en) 2019-01-31 2019-01-31 A kind of chlorhexidine acetate bacteriostatic gel and preparation method thereof

Publications (1)

Publication Number Publication Date
CN109602696A true CN109602696A (en) 2019-04-12

Family

ID=66019243

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201910097605.XA Withdrawn CN109602696A (en) 2019-01-31 2019-01-31 A kind of chlorhexidine acetate bacteriostatic gel and preparation method thereof

Country Status (1)

Country Link
CN (1) CN109602696A (en)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110063914A (en) * 2019-05-21 2019-07-30 张静 A plant extraction ferment cleans bubble
CN112057370A (en) * 2020-10-19 2020-12-11 青岛浩大生物科技工程有限责任公司 Private antibacterial foaming agent and preparation method thereof
CN112315900A (en) * 2020-11-06 2021-02-05 南京道大药业有限公司 Gel for nursing private parts of women
CN116139233A (en) * 2023-03-30 2023-05-23 天津美丽之约生物科技发展有限公司 Female private care antibacterial liquid and preparation process thereof

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN110063914A (en) * 2019-05-21 2019-07-30 张静 A plant extraction ferment cleans bubble
CN112057370A (en) * 2020-10-19 2020-12-11 青岛浩大生物科技工程有限责任公司 Private antibacterial foaming agent and preparation method thereof
CN112315900A (en) * 2020-11-06 2021-02-05 南京道大药业有限公司 Gel for nursing private parts of women
CN116139233A (en) * 2023-03-30 2023-05-23 天津美丽之约生物科技发展有限公司 Female private care antibacterial liquid and preparation process thereof

Similar Documents

Publication Publication Date Title
CN109602696A (en) A kind of chlorhexidine acetate bacteriostatic gel and preparation method thereof
CN109568206B (en) Special antibacterial composition and lotion for women and preparation method thereof
CN104940122B (en) A kind of leave Feminine care solution and preparation method thereof
CN102697961B (en) Gynecological cleaning solution and preparation method thereof
CN108853311A (en) A kind of Traditional Chinese medicine gel composition antibacterial for vagina mucosa
CN113081928A (en) Plant bacteriostatic gel and preparation method and application thereof
CN103705649A (en) Sterilization disinfectant used for clinical laboratory and preparation method of sterilization disinfectant
CN109010526A (en) One kind is for the antibacterial clean Traditional Chinese medicine gel composition of maintenance of vaginal mucosa
CN103494958A (en) Traditional Chinese medicine lotion for treating gynecological inflammations as well as preparation method thereof
CN109602813A (en) A kind of bacteriostatic gel and preparation method thereof
CN105662996A (en) Traditional Chinese medicine mask for treating menstruation-associated acne
CN105169339A (en) Traditional Chinese medicine cleaning fluid for treating gynecologic inflammation
CN104288552A (en) Vagina-cleaning care solution and preparation method thereof
CN105535723A (en) Traditional Chinese medicinal composition for treating vulvitis and external preparation of traditional Chinese medicinal composition
CN108403570A (en) There are the body condensation and preparation method of improvement to pruitus caused by eczema
CN114869945A (en) Traditional Chinese medicine composition and preparation for treating skin wound fester as well as preparation method and application of traditional Chinese medicine composition and preparation
CN107536923A (en) A kind of oldenlandia diffusa antibacterial gel
CN103599437B (en) One treats colpitic traditional Chinese medicine liquid
CN106620146A (en) Tampon for relieving and treating gynecological inflammations and preparation method of tampon
CN107875404B (en) Skin-moistening type medical ultrasonic coupling agent and preparation method and use method thereof
CN106177687A (en) For external medicine composition treating gynecological inflammation and preparation method thereof
KR101125758B1 (en) A detergent composition for cleaning the women's genital area
CN106038429A (en) Traditional Chinese medicinal liquid soap with sterilization effect and preparation method for traditional Chinese medicinal liquid soap
CN102078546A (en) Gynecological medical lotion for external use
CN105287935A (en) Traditional Chinese medicine for treating seminal vesiculitis

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
WW01 Invention patent application withdrawn after publication

Application publication date: 20190412

WW01 Invention patent application withdrawn after publication